1 min read
Add as a preferred source on GooglePrime Medicine Expects About $125 Million in Gross Offering Proceeds
The company priced 35,714,286 common shares at $3.50 apiece.
Prime Medicine priced 35,714,286 common shares at $3.50 each, and expects the public offering to generate about $125 million in gross proceeds before underwriting discounts, commissions and offering expenses.
The expected proceeds estimate excludes the underwriters’ option to purchase additional shares.
John Kim
John Kim reports on the digital-asset business for TokenPost. Send corrections or tips to info@tokenpost.com.